0.3069
Accuray Inc stock is traded at $0.3069, with a volume of 3.65M.
It is up +0.10% in the last 24 hours and down -34.34% over the past month.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
See More
Previous Close:
$0.3066
Open:
$0.3094
24h Volume:
3.65M
Relative Volume:
1.60
Market Cap:
$36.51M
Revenue:
$436.97M
Net Income/Loss:
$-35.62M
P/E Ratio:
-1.0288
EPS:
-0.2983
Net Cash Flow:
$-10.71M
1W Performance:
+13.67%
1M Performance:
-34.34%
6M Performance:
-70.77%
1Y Performance:
-80.58%
Accuray Inc Stock (ARAY) Company Profile
Name
Accuray Inc
Sector
Industry
Phone
608-824-2800
Address
1240 DEMING WAY, MADISON, CA
Compare ARAY vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ARAY
Accuray Inc
|
0.3069 | 36.47M | 436.97M | -35.62M | -10.71M | -0.2983 |
|
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-24 | Initiated | ROTH MKM | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Loop Capital | Buy |
| Jan-21-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-01-18 | Upgrade | Citigroup | Sell → Neutral |
| Dec-13-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-17 | Initiated | Lake Street | Buy |
| Dec-14-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-22-15 | Initiated | RBC Capital Mkts | Sector Perform |
| Nov-12-15 | Initiated | Citigroup | Sell |
| May-01-15 | Reiterated | Dougherty & Company | Buy |
| Jan-12-15 | Initiated | Northland Capital | Outperform |
| Jan-31-14 | Reiterated | Dougherty & Company | Buy |
| Jan-29-14 | Reiterated | Brean Capital | Buy |
| Nov-11-13 | Reiterated | Dougherty & Company | Buy |
| Aug-29-13 | Reiterated | Dougherty & Company | Buy |
| Sep-20-11 | Reiterated | Ticonderoga | Buy |
| Feb-08-10 | Upgrade | Jefferies & Co | Hold → Buy |
| Dec-09-09 | Upgrade | UBS | Sell → Neutral |
| Mar-09-09 | Downgrade | Soleil | Buy → Hold |
| Jan-30-09 | Upgrade | Piper Jaffray | Neutral → Buy |
| Dec-22-08 | Reiterated | Jefferies & Co | Hold |
| Aug-20-08 | Reiterated | Jefferies & Co | Hold |
View All
Accuray Inc Stock (ARAY) Latest News
TCW Group boosts Accuray (ARAY) stake to 13.7% through loan-linked warrants - Stock Titan
ARAY Stock Price, Quote & Chart | ACCURAY INC (NASDAQ:ARAY) - ChartMill
TCW Group (NASDAQ: ARAY) affiliates receive Accuray warrants tied to term loan - Stock Titan
Accuray brings AI in radiotherapy to ESTRO stage focusing on clinical performance and ethics - Traders Union
Accuray showcases Radixact system for paediatric radiotherapy at ESTRO conference - Traders Union
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Accuray and University of Wisconsin launch 10-year deal to advance personalized cancer radiation therapy. - Pluang
Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer – Company Announcement - Financial Times
Accuray Company Profile & Introduction - Moomoo
News Flash: 2 Analysts Think Accuray Incorporated (NASDAQ:ARAY) Earnings Are Under Threat - Moomoo
Accuray Shares Fall After Jefferies Downgrade - Moomoo
Accuray Inc (ARAY) Runs Into Middle East Headwinds, But Shift Plan Is Working - Insider Monkey
Accuray, Aevex, Zoetis - TradingView
Jefferies Downgrades Accuray(ARAY.US) to Hold Rating, Cuts Target Price to $0.35 - 富途牛牛
Jefferies Downgrades Accuray to Hold From Buy, Adjusts Price Target to $0.35 From $3.50 - marketscreener.com
Jefferies downgrades Accuray stock rating on guidance withdrawal - Investing.com UK
Jefferies downgrades Accuray stock rating on guidance withdrawal By Investing.com - Investing.com South Africa
Accuray Slides As Insider Purchases Lose Another US$95k - Yahoo Finance
Accuray (ARAY) Q3 2026 Earnings Transcript - AOL.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
This PayPal Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Sahm
ARAY Reports Q3 Revenue Decline Amid Strategic Advancements - GuruFocus
ARAY Downgraded by BTIG -- Rating Changed to Neutral - GuruFocus
Accuray Incorporated (NASDAQ:ARAY) Q3 2026 Earnings Call Transcript - Insider Monkey
Accuray Q3 FY26 slides: guidance withdrawn amid geopolitical turmoil By Investing.com - Investing.com Canada
Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026 - Investing News Network
BTIG downgrades Accuray stock rating on revenue challenges and guidance withdrawal - Investing.com Canada
BTIG Downgrades Accuray(ARAY.US) to Hold Rating - Moomoo
Accuray: Fiscal Q3 Earnings Snapshot - theheraldreview.com
Accuray Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Accuray Q3 Earnings Call Highlights - Yahoo Finance
Accuray IncWithdraws FY2026 Financial Guid - Moomoo
Earnings call transcript: Accuray’s Q3 2026 results miss forecasts, shares drop - Investing.com
Accuray Inc (NASDAQ:ARAY) Plunges 12.5% After Fiscal Q3 Earnings Miss - ChartMill
Accuray Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 - marketscreener.com
Rising interest, restructuring deepen Accuray (NASDAQ: ARAY) losses and add covenant risk - Stock Titan
[8-K] ACCURAY INC Reports Material Event - Stock Titan
Accuray Reports Fiscal 2026 Third Quarter Financial Results - ChartMill
Accuray Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
MSN Money - MSN
Earnings Preview: Accuray to Report Financial Results Post-market on May 06 - Moomoo
Accuray Incorporated Files Form 8-K Report with SEC Detailing Company Information and Compliance Data - Minichart
Operations chief Leonel Peralta exits Accuray (NASDAQ: ARAY) leadership team - Stock Titan
Accuray Incorporated Announces Departure of Leonel Peralta as Senior Vice President, Chief Operations Officer, Effective April 26, 2026 - marketscreener.com
Accuray Inc (STU:XEJ) Stock Price & 30 Year Financial Data - GuruFocus
ARAY (Accuray Incorporated) Q1 2026 narrow EPS beat and modest revenue growth drive small share gains.Fast Rising Picks - Cổng thông tin điện tử tỉnh Lào Cai
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now - MSN
Accuray Inc Stock (ARAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):